LSX Investival 2026
IDEVAX is joining the LSX Investival on 16 November 2025 at Old Billingsgate, London. Meet our team, Koen Beyers (CTO & Founder) and Vanessa Vankerckhoven (CEO & Founder), to discover VAX-ID, our CE-marked intradermal device designed to improve accuracy, efficacy, and accessibility in vaccination, drug delivery, and diagnostics. Join us for the IDEVAX presentation at 11:30 AM on the TechBio & Digital Showcase Stage to learn more about our innovative approach.
Interested in our solutions?
Contact our commercial team!